|
|
|
|
Evaluation of the Pangenotypic HCV NS3/4A Protease
Inhibitor GS-9857 in Healthy Volunteers
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Brian J. Kirby, Jenny C. Yang, Chris Yang, Qinghua Song, Yi Wang, James G. Taylor, Luisa M. Stamm, Anita Mathias
Gilead Sciences, Inc., Foster City, California, USA
|
|
|
|
|
|
|